JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tongsong, T.
Right arrow Articles by Chanprapaph, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tongsong, T.
Right arrow Articles by Chanprapaph, P.
© 2004 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 23:49-55 • 0278-4297

Sonographic Markers of Hemoglobin Bart Disease at Midpregnancy

Theera Tongsong, MD, Chanane Wanapirak, MD, Supatra Sirichotiyakul, MD and Pharuhas Chanprapaph, MD

Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Address correspondence and reprint requests to Theera Tongsong, MD, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. E-mail: ttongson{at}mail.med.cmu.ac.th.

Objective. To evaluate the efficacy of various sonographic markers at midpregnancy in predicting fetal hemoglobin Bart disease. Methods. Four hundred eighty-eight pregnancies at risk of having fetuses with hemoglobin Bart disease were recruited for prenatal diagnosis with cordocentesis at 18 to 21 gestational weeks. Before cordocentesis, the sonographic markers, including cardiothoracic ratio, placental thickness, pericardial effusion, pleural effusion, ascites, subcutaneous edema, cord edema, dilated umbilical vein, and amniotic fluid index, were assessed and recorded. The definite fetal diagnosis was based on blood analysis. The efficacy of each sonographic marker in predicting hemoglobin Bart disease was evaluated by sensitivity and specificity. Results. Among 488 pregnancies undergoing prenatal diagnosis, 100 fetuses were proved to be affected by hemoglobin Bart disease. The cardiothoracic ratio gave the highest sensitivity, 95.0%, with specificity of 96.1%, followed by placental thickness. Signs of hydrops fetalis were observed in 33.0% of cases; they did not increase the sensitivity of the cardiothoracic ratio but strongly reinforced the diagnosis when they appeared. Conclusions. At midpregnancy, sonographic markers can effectively differentiate normal pregnancies from those with fetal hemoglobin Bart disease. Among couples at risk with no sonographic markers, the risk of having an affected child is nearly eliminated. The most sensitive marker was the cardiothoracic ratio, followed by placental thickness.

Key Words: cardiothoracic ratio • hemoglobin Bart disease • hydrops fetalis • sonography • thalassemia

Abbreviations: C/T, cardiothoracic • Hb, hemoglobin • HPLC, high-performance liquid chromatography




This article has been cited by other articles:


Home page
Clin. Chem.Home page
D. Li
A Multiplex Quantitative Fluorescent PCR Test for Prenatal Diagnosis of Hb Barts Hydrops Fetalis
Clin. Chem., May 1, 2007; 53(5): 991 - 992.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. H.K. CHUI
{alpha}-Thalassemia: Hb H Disease and Hb Barts Hydrops Fetalis
Ann. N.Y. Acad. Sci., November 1, 2005; 1054(1): 25 - 32.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Institute of Ultrasound in Medicine.